| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537137 | Vaccine | 2017 | 8 Pages |
Abstract
Our findings support evidence that routine MCC vaccination was the driving force behind the decreasing SgC trend. Vaccinating against SgB in the first year of life could help reduce the burden of IMD due to this serogroup. Changing serogroup-specific NR trends highlight the need for high-quality surveillance data to accurately assess the changing epidemiology of IMD, the effectiveness and impact of implemented vaccines, and the need for future vaccines.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Robert Whittaker, Joana Gomes Dias, Miriam Ramliden, Csaba Ködmön, Assimoula Economopoulou, Netta Beer, Lucia Pastore Celentano,